Ohio State University Hospital
Columbus, Ohio 43211
7 studies enrolling now · 31 studies all time
What they study most
Acute Decompensated Heart Failure, Advanced Solid Tumor, Alzheimer's Disease, Any Solid Tumor, B-cell Lymphoma, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Cervical Length, Chronic Lymphocytic Leukemia, Colon Cancer, Colorectal Carcinoma, Coronary Artery Bypass Grafting
Studies at this site
- A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
- Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma — Recruiting now
- US Post-Market Surveillance Study of the Surfacer System — Recruiting now
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
- Ketogenic Diet to Improve Neuro-recovery — Recruiting now
- Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy — Running, not enrolling
- Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation: — Starting soon
- Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS) — Running, not enrolling
- Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean — Completed
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) — Completed
- Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling
- Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
- A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
- A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL — Completed
- Pravastatin to Prevent Preeclampsia — Stopped early
- A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment — Running, not enrolling
- Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
- Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases — Running, not enrolling
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed
- A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
- mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Withdrawn before enrolling
- Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study — Completed
- Fluid Responsiveness Evaluation in Sepsis-associated Hypotension — Completed
- RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix — Stopped early
- Gestational Diabetes Mellitus Trial (GDM) — Completed
- A Randomized Trial of Induction Versus Expectant Management — Completed
- Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass — Completed
- MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
- Wireless, Intermittent Monitoring of Right Heart Pressures in HF — Completed
- Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed